Think Tanks et al

Think Tanks et al
Accessed 16 Feb 2019
[No new relevant content]

Center for Global Development
February 7, 2019
Gavi Going Forward: Immunization for Every Child Everywhere?
In December 2018, the Gavi Alliance hosted a mid-term review to assess progress towards its core purpose: “reach every child everywhere with vaccines against preventable diseases.” The good news is that there’s been advances on new vaccine introductions, and an estimated 65 million children were immunized with Gavi-supported new and underutilized vaccines in 2017.     The bad news? There is still huge variability on the measure that counts most for building herd immunity and reducing vaccine-preventable disease: full vaccination for age among children under 2 years old.
Amanda Glassman and Liesl Schnabel

Accessed 16 Feb 2019
Saving Lives in a Time of Crisis: Why the Global Humanitarian System Matters
February 14, 2019

Council on Foreign Relations
Accessed 16 Feb 2019
[No new relevant content]


Kaiser Family Foundation
Accessed 16 Feb 2019
February 15, 2019 News Release
Analysis Finds that Medications for Hepatitis C and HIV/AIDS Are the Costliest Group of Outpatient Prescription Drugs for Medicaid, While Diabetes Drugs Have Posted the Sharpest Rise in Costs 
Antiviral medications, including those that treat hepatitis C and HIV/AIDS, cost the Medicaid program more money (before rebates) than any other group of outpatient prescription drugs for each year from 2014 to 2017, according to a new KFF analysis.